PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 160 filers reported holding PTC THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,131,000 | +13.7% | 120,827 | 0.0% | 0.23% | -4.5% |
| Q1 2020 | $5,390,000 | +13.0% | 120,827 | +21.6% | 0.24% | +35.6% |
| Q4 2019 | $4,771,000 | -5.0% | 99,327 | -33.1% | 0.18% | -17.8% |
| Q3 2019 | $5,020,000 | -20.1% | 148,435 | +6.3% | 0.22% | -14.5% |
| Q2 2019 | $6,282,000 | +143.1% | 139,608 | +103.4% | 0.26% | +143.8% |
| Q1 2019 | $2,584,000 | +9.7% | 68,652 | 0.0% | 0.10% | +4.0% |
| Q4 2018 | $2,356,000 | +3.6% | 68,652 | +41.9% | 0.10% | +23.2% |
| Q3 2018 | $2,274,000 | +245.6% | 48,390 | +99.1% | 0.08% | +215.4% |
| Q1 2018 | $658,000 | -89.3% | 24,299 | -79.6% | 0.03% | -91.0% |
| Q4 2014 | $6,168,000 | +77.1% | 119,150 | +50.5% | 0.29% | +77.3% |
| Q3 2014 | $3,483,000 | +68.3% | 79,150 | 0.0% | 0.16% | -14.2% |
| Q2 2014 | $2,069,000 | 0.0% | 79,150 | 0.0% | 0.19% | -8.2% |
| Q1 2014 | $2,069,000 | – | 79,150 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |